Kymera Therapeutics, Inc. - KYMR

SEC FilingsOur KYMR Tweets

About Gravity Analytica

Recent News

  • 06.26.2025 - Wolfe Research Virtual Biotech Day
  • 06.26.2025 - Wolfe Research Virtual Biotech Day
  • 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.05.2025 - Jefferies Global Healthcare Conference
  • 06.05.2025 - Jefferies Global Healthcare Conference
  • 06.02.2025 - Kymera Therapeutics KT-621 Phase 1 Healthy Volunteer Results
  • 06.02.2025 - Kymera Therapeutics KT-621 Phase 1 Healthy Volunteer Results
  • 06.02.2025 - Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
  • 06.02.2025 - Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader

Recent Filings

  • 06.02.2025 - EX-99.1 EX-99.1
  • 06.02.2025 - EX-99.1 EX-99.1
  • 06.02.2025 - 8-K Current report
  • 06.02.2025 - 8-K Current report
  • 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.23.2025 - 144 Report of proposed sale of securities